Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

NICHOLAS J PROCACCINI

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1336351147
CMS profile
14920
Location
SEATTLE, WA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$1,968.24

83 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,968.24 83

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 2; records 51–83 of 83 matching records. This page contains 33 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

NICHOLAS J PROCACCINI

NPI 1336351147 · CMS profile ID 14920

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

SEATTLE, WA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–83 of 83 matching records. This page contains 33 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1336351147?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
NICHOLAS J PROCACCINI, NPI 1336351147, CMS profile ID 14920. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–83 of 83 matching records. This page contains 33 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1336351147?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). NICHOLAS J PROCACCINI, NPI 1336351147, CMS profile ID 14920. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–83 of 83 matching records. This page contains 33 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1336351147?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
NICHOLAS J PROCACCINI, NPI 1336351147, CMS profile ID 14920, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–83 of 83 matching records. This page contains 33 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1336351147?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

83 matching records · $1,968.24 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 83 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–83 of 83.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Takeda Pharmaceuticals U.S.A., Inc. $24.5405/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223892868 CMS
ABBVIE INC. $19.9905/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203690390 CMS
ABBVIE INC. $1.5305/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203690395 CMS
Janssen Biotech, Inc. $18.5605/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175330556 CMS
ABBVIE INC. $27.2404/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203690383 CMS
ABBVIE INC. $15.4204/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203690378 CMS
Janssen Biotech, Inc. $28.0804/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175325428 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.1504/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223867246 CMS
Daiichi Sankyo Inc. $29.4704/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197097393 CMS
QOL Medical, LLC $22.6604/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1185020418 CMS
Madrigal Pharmaceuticals $24.0504/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248300406 CMS
Digestive Care, Inc. $12.1304/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1173586776 CMS
ABBVIE INC. $28.4304/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203690372 CMS
Ipsen Biopharmaceuticals, Inc $30.8003/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208836405 CMS
ABBVIE INC. $29.6303/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203690366 CMS
Regeneron Healthcare Solutions, Inc. $26.4003/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213017150 CMS
Takeda Pharmaceuticals U.S.A., Inc. $29.3003/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223918356 CMS
Lilly USA, LLC $23.1203/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186803339 CMS
ABBVIE INC. $28.2702/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203690361 CMS
ABBVIE INC. $30.5402/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203690357 CMS
Janssen Biotech, Inc. $15.6302/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175325625 CMS
Madrigal Pharmaceuticals $21.3802/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248300402 CMS
Madrigal Pharmaceuticals $3.7802/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248300404 CMS
Aimmune Therapeutics, Inc. $27.6702/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249712841 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.8402/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223880453 CMS
Janssen Biotech, Inc. $23.7202/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175328449 CMS
ABBVIE INC. $32.3702/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203690351 CMS
Celltrion USA Inc. $25.3802/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250830072 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.6802/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223906264 CMS
Janssen Biotech, Inc. $25.8401/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175326854 CMS
Intercept Pharmaceuticals, Inc. $16.8901/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249875256 CMS
GENZYME CORPORATION $33.4001/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233206443 CMS
Madrigal Pharmaceuticals $26.2401/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248300400 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $97.62 2
PY2020 $38.12 2
PY2023 $56.27 2
PY2024 $1,964.08 68
PY2025 $1,968.24 83

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $61,185.15 13
PY2024 Principal investigator $67,317.75 8
PY2019 Principal investigator $17,644.88 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Eli Lilly and Company $1,395.66 12/17/2025 Non-covered Recipient Entity
WASHINGTON GASTROENTEROLOGY PLLC
A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE PHARMACOLOGIC AGENTS IN ADULT PARTICIPANTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE WHO ARE AT INCREASED RISK OF DEVELOPING MAJOR ADVERSE LIVER OUTCOMES No dispute reported 06/30/2026 1187891538
Principal investigator 1 Eli Lilly and Company $915.38 12/17/2025 Non-covered Recipient Entity
WASHINGTON GASTROENTEROLOGY PLLC
A MASTER PROTOCOL FOR A RANDOMIZED, CONTROLLED, CLINICAL TRIAL OF MULTIPLE PHARMACOLOGIC AGENTS IN ADULT PARTICIPANTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE WHO ARE AT INCREASED RISK OF DEVELOPING MAJOR ADVERSE LIVER OUTCOMES No dispute reported 06/30/2026 1187893466
Principal investigator 1 ABBVIE INC. $1,134.30 10/23/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn Disease Who Completed the Studies M14-431 or M14-433 No dispute reported 06/30/2026 1202518399
Principal investigator 1 ABBVIE INC. $1,200.00 10/23/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn Disease Who Completed the Studies M14-431 or M14-433 No dispute reported 06/30/2026 1202518401
Principal investigator 1 Eli Lilly and Company $64.26 10/20/2025 Non-covered Recipient Entity
WASHINGTON GASTROENTEROLOGY PLLC
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED STUDY OF LY4268989 (MORF-057) CO-ADMINISTERED WITH MIRIKIZUMAB IN ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 1187893290
Principal investigator 1 ABBVIE INC. $8,103.00 08/05/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn Disease Who Completed the Studies M14-431 or M14-433 No dispute reported 06/30/2026 1202502060
Principal investigator 1 ABBVIE INC. $21,500.00 07/02/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab (REVAMP) No dispute reported 06/30/2026 1202495827
Principal investigator 1 ABBVIE INC. $2,360.40 05/06/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn Disease Who Completed the Studies M14-431 or M14-433 No dispute reported 06/30/2026 1202481329
Principal investigator 1 Eli Lilly and Company $15,334.00 03/04/2025 Non-covered Recipient Entity
WASHINGTON GASTROENTEROLOGY PLLC
A PHASE 3, MULTICENTER, OPEN LABEL, LONG TERM EXTENSION STUDY TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH CROHNS DISEASE No dispute reported 06/30/2026 1187893780
Principal investigator 1 Eli Lilly and Company $54.75 02/25/2025 Non-covered Recipient Entity
WASHINGTON GASTROENTEROLOGY PLLC
A PHASE 3, MULTICENTER, OPEN LABEL, LONG TERM EXTENSION STUDY TO EVALUATE THE LONG TERM EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH CROHNS DISEASE No dispute reported 06/30/2026 1187893288
Principal investigator 1 ABBVIE INC. $1,421.60 02/06/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
M14-430 - A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn Disease Who Completed the Studies M14-431 or M14-433 No dispute reported 06/30/2026 1202449113
Principal investigator 1 Eli Lilly and Company $5,350.00 01/22/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS
A MULTICENTER, PHASE 3B, OPEN-LABEL, SINGLE-ARM STUDY TO INVESTIGATE BOWEL URGENCY AND ITS RELATIONSHIP WITH OTHER OUTCOME MEASURES IN ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB No dispute reported 06/30/2026 1187891734
Principal investigator 1 ABBVIE INC. $2,351.80 01/02/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
M14-430 - A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn Disease Who Completed the Studies M14-431 or M14-433 No dispute reported 06/30/2026 1202435516